The Patient Deficit Model Overturned: a qualitative study of patients' perceptions of invitation to participate in a randomized controlled trial comparing selective bladder preservation against surgery in muscle invasive bladder cancer (SPARE, CRUK/07/011).
SPARE Trial Management Group
MetadataShow full item record
<h4>Background</h4>Evidence suggests that poor recruitment into clinical trials rests on a patient 'deficit' model - an inability to comprehend trial processes. Poor communication has also been cited as a possible barrier to recruitment. A qualitative patient interview study was included within the feasibility stage of a phase III non-inferiority Randomized Controlled Trial (RCT) (SPARE, CRUK/07/011) in muscle invasive bladder cancer. The aim was to illuminate problems in the context of randomization.<h4>Methods</h4>The qualitative study used a 'Framework Analysis' that included 'constant comparison' in which semi-structured interviews are transcribed, analyzed, compared and contrasted both between and within transcripts. Three researchers coded and interpreted data.<h4>Results</h4>Twenty-four patients agreed to enter the interview study; 10 decliners of randomization and 14 accepters, of whom 2 subsequently declined their allocated treatment.The main theme applying to the majority of the sample was confusion and ambiguity. There was little indication that confusion directly impacted on decisions to enter the SPARE trial. However, confusion did appear to impact on ethical considerations surrounding 'informed consent', as well as cause a sense of alienation between patients and health personnel.Sub-optimal communication in many guises accounted for the confusion, together with the logistical elements of a trial that involved treatment options delivered in a number of geographical locations.<h4>Conclusions</h4>These data highlight the difficulty of providing balanced and clear trial information within the UK health system, despite best intentions. Involvement of multiple professionals can impact on communication processes with patients who are considering participation in RCTs. Our results led us to question the 'deficit' model of patient behavior. It is suggested that health professionals might consider facilitating a context in which patients feel fully included in the trial enterprise and potentially consider alternatives to randomization where complex interventions are being tested.<h4>Trial registration</h4>ISRCTN61126465.
Version of record
SPARE Trial Management Group
Attitude of Health Personnel
Health Knowledge, Attitudes, Practice
Patient Acceptance of Health Care
Urinary Bladder Neoplasms
Interviews as Topic
Organ Sparing Treatments
Clinical Trials & Statistics Unit
ICR-CTSU Urology and Head and Neck Trials Team
Clinical Academic Radiotherapy (Huddart)
License start date
Trials, 2012, 13 pp. 228 - ?
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/
Showing items related by title, author, creator and subject.
Fatigue in Advanced Cancer Patients: Congruence Between Patients and Their Informal Caregivers About Patients' Fatigue Severity During Cancer Treatment With Palliative Intent and Predictors of Agreement. Poort, H; Peters, MEWJ; Gielissen, MFM; Verhagen, CAHHVM; Bleijenberg, G; van der Graaf, WTA; Wearden, AJ; Knoop, H (2016-09)<h4>Context</h4>Informal caregivers (ICs) are increasingly involved in the monitoring of symptoms during advanced cancer patients' treatment with palliative intent. A common but subjective symptom during this extended ...
Treatment demands and differential treatment of patients with cystic fibrosis and their siblings: patient, parent and sibling accounts Foster, C; Eiser, C; Oades, P; Sheldon, C; Tripp, J; Goldman, P; Rice, S; Trott, J (BLACKWELL SCIENCE LTD, 2001-07)Cystic fibrosis (CF) is a progressive disease with no known cure. Advances in diagnosis and treatment have resulted in patients living longer and thus families live with the illness for longer. Treatments are becoming ...
Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors Izumchenko, E; Paz, K; Ciznadija, D; Sloma, I; Katz, A; Vasquez-Dunddel, D; Ben-Zvi, I; Stebbing, J; McGuire, W; Harris, W; Maki, R; Gaya, A; Bedi, A; Zacharoulis, S; Ravi, R; Wexler, LH; Hoque, MO; Rodriguez-Galindo, C; Pass, H; Peled, N; Davies, A; Morris, R; Hidalgo, M; Sidransky, D (Elsevier BV, 2017-10)